These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32739481)

  • 1. Design and synthesis of pinane oxime derivatives as novel anti-influenza agents.
    Dong J; Xiao M; Ma Q; Zhang G; Zhao W; Kong M; Zhang Y; Qiu L; Hu W
    Bioorg Chem; 2020 Sep; 102():104106. PubMed ID: 32739481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus.
    Dong J; Chen S; Li R; Cui W; Jiang H; Ling Y; Yang Z; Hu W
    Eur J Med Chem; 2016 Jan; 108():605-615. PubMed ID: 26722757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.
    Wu Y; Canturk B; Jo H; Ma C; Gianti E; Klein ML; Pinto LH; Lamb RA; Fiorin G; Wang J; DeGrado WF
    J Am Chem Soc; 2014 Dec; 136(52):17987-95. PubMed ID: 25470189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
    Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
    Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-influenza activity of monoterpene-containing substituted coumarins.
    Khomenko TM; Zarubaev VV; Orshanskaya IR; Kadyrova RA; Sannikova VA; Korchagina DV; Volcho KP; Salakhutdinov NF
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2920-2925. PubMed ID: 28501512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Structure Activity Relationship and Anti-influenza A Virus Evaluation of Oleanolic Acid-Linear Amino Derivatives.
    Li W; Yang F; Meng L; Sun J; Su Y; Shao L; Zhou D; Yu F
    Chem Pharm Bull (Tokyo); 2019 Nov; 67(11):1201-1207. PubMed ID: 31434835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
    Su Y; Meng L; Sun J; Li W; Shao L; Chen K; Zhou D; Yang F; Yu F
    Eur J Med Chem; 2019 Nov; 182():111622. PubMed ID: 31425909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with
    Cáceres CJ; Hu Y; Cárdenas-García S; Wu X; Tan H; Carnaccini S; Gay LC; Geiger G; Ma C; Zhang QY; Rajao D; Perez DR; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):1832-1848. PubMed ID: 34427541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses.
    Hu Y; Wang Y; Li F; Ma C; Wang J
    Eur J Med Chem; 2017 Jul; 135():70-76. PubMed ID: 28433777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
    Musharrafieh R; Ma C; Wang J
    Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
    Kolocouris A; Tzitzoglaki C; Johnson FB; Zell R; Wright AK; Cross TA; Tietjen I; Fedida D; Busath DD
    J Med Chem; 2014 Jun; 57(11):4629-39. PubMed ID: 24793875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors.
    Wu S; Huang J; Gazzarrini S; He S; Chen L; Li J; Xing L; Li C; Chen L; Neochoritis CG; Liao GP; Zhou H; Dömling A; Moroni A; Wang W
    ChemMedChem; 2015 Nov; 10(11):1837-45. PubMed ID: 26506405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.
    Yu Y; Tang Q; Xu Z; Li S; Jin M; Zhao Z; Dong C; Wu S; Zhou HB
    Eur J Med Chem; 2018 Nov; 159():206-216. PubMed ID: 30292897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.
    de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S
    Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.